Strain SummaryB6.129P2-Xpatm1Hvs
Strain Name |
B6.129P2-Xpatm1Hvs |
Strain Type(s) |
congenic • targeted mutation (knockout) |
Strain Synonym(s) |
C57BL/6 Xpa • C57Bl/6J-TgH(XPAIm)55Cmg • Xpa • Xpa homozygous knockout • Xpa-/- • XPA |
Description |
Homozygous mice. The genetic background of these mice is backcrossed C57BL/6J with the targeted mutation having been generated on a 129P2/OlaHsd background. |
Strain Genetics |
Xpatm1Hvs / Xpatm1Hvs |
| Frequency | ||||||||
|---|---|---|---|---|---|---|---|---|
| Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
| Adipose tissue lipoma | Abdominal cavity |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Adipose tissue lipoma | CNS - Brain |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Adipose tissue lipoma | CNS - Brain | estradiol (E2) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex |
0 |
2.2 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
0 - 1.1 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla | diethylstilbestrol (DES) |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Adrenal gland - Subcapsular cell hyperplasia | Adrenal gland - Subcapsular cell |
100 |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Adrenal gland - Subcapsular cell hyperplasia | Adrenal gland - Subcapsular cell | diethylstilbestrol (DES) |
100 |
60 - 87 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||
| Blood vessel hemangiosarcoma | Blood vessel |
0 |
0.6 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Bone lesion | Bone - Sternum |
0 |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Bone lesion | Bone - Femur |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Bone lesion | Bone - Sternum | diethylstilbestrol (DES) |
0 - 60 |
0 - 47 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||
| Bone lesion | Bone - Femur | diethylstilbestrol (DES) |
0 - 100 |
0 - 93 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||
| Bone lesion - fibro-osseous | Bone |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Bone lesion - fibro-osseous | Bone | estradiol (E2) |
100 |
46.7 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Bone osteosarcoma | Bone |
0 - 0.6 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Bone osteosarcoma | Bone | diethylstilbestrol (DES) |
0 |
0 - 6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Bone osteosarcoma | Bone - Sternum | diethylstilbestrol (DES) |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 Sites of Metastasis: not (Unspecified organ) |
||||
| Bone osteosarcoma | Bone | estradiol (E2) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| CNS - Brain - Cerebrum glioma | CNS - Brain - Cerebrum |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| CNS - Brain - Cerebrum glioma | CNS - Brain - Cerebrum | diethylstilbestrol (DES) |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||
| CNS - Brain glioma | CNS - Brain |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| CNS - Brain glioma | CNS - Brain | diethylstilbestrol (DES) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Connective tissue - Fibroblast fibrosarcoma | Uterus - Cervix |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||||
| Connective tissue - Fibroblast fibrosarcoma | Uterus - Cervix | diethylstilbestrol (DES) |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Skin |
0 |
0.6 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Forestomach papilloma | Forestomach | benzo[a]pyrene (BP) (BaP) (B[a]P) |
13 |
13 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||
| Forestomach squamous cell carcinoma | Forestomach | benzo[a]pyrene (BP) (BaP) (B[a]P) |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Forestomach tumor | Forestomach | benzo[a]pyrene (BP) (BaP) (B[a]P) |
0 - 40 |
0 - 33.3 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Gallbladder papilloma | Gallbladder | 2-acetamidofluorene (2-AAF) |
26.7 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Intestine - Large Intestine - Cecum adenoma | Intestine - Large Intestine - Cecum | benzo[a]pyrene (BP) (BaP) (B[a]P) |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Intestine - Small Intestine - Duodenum adenocarcinoma | Intestine - Small Intestine - Duodenum | benzo[a]pyrene (BP) (BaP) (B[a]P) |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Intestine - Small Intestine - Duodenum adenoma | Intestine - Small Intestine - Duodenum | benzo[a]pyrene (BP) (BaP) (B[a]P) |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Intestine - Small Intestine - Ileum adenocarcinoma | Intestine - Small Intestine - Ileum | benzo[a]pyrene (BP) (BaP) (B[a]P) |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Intestine - Small Intestine - Ileum adenoma | Intestine - Small Intestine - Ileum | benzo[a]pyrene (BP) (BaP) (B[a]P) |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Intestine - Small Intestine - Jejunum adenocarcinoma | Intestine - Small Intestine - Jejunum | benzo[a]pyrene (BP) (BaP) (B[a]P) |
20 |
20 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||
| Intestine - Small Intestine - Jejunum adenoma | Intestine - Small Intestine - Jejunum | benzo[a]pyrene (BP) (BaP) (B[a]P) |
20 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Intestine - Small Intestine adenocarcinoma | Intestine - Small Intestine |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Intestine - Small Intestine adenocarcinoma | Intestine - Small Intestine | WY-14,643 |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Intestine - Small Intestine tumor | Intestine - Small Intestine |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Intestine tumor | Intestine | benzo[a]pyrene (BP) (BaP) (B[a]P) |
0 - 46.7 |
0 - 26.7 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Kidney hyperplasia | Kidney | phenacetin |
observed |
observed |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Kidney transitional cell carcinoma | Kidney | p-cresidine |
0 |
0 - 6.7 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Kidney tumor | Kidney | phenacetin |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Leukocyte - Lymphocyte - B-lymphocyte lymphoma | Leukocyte - Lymphocyte - B-lymphocyte | benzo[a]pyrene (BP) (BaP) (B[a]P) |
20 |
13 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 Sites of Metastasis: (Unspecified organ) , Liver |
|||
| Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Leukocyte - Lymphocyte - T-lymphocyte |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Leukocyte - Lymphocyte - T-lymphocyte | diethylstilbestrol (DES) |
0 |
0 - 6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 Sites of Metastasis: (Unspecified organ) |
|||
| Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Leukocyte - Lymphocyte - T-lymphocyte | benzo[a]pyrene (BP) (BaP) (B[a]P) |
6.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 Sites of Metastasis: (Unspecified organ) , Liver |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
0 |
0.6 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) | estradiol (E2) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Leukocyte - Myelocyte (Granulocyte) sarcoma - myeloid | Leukocyte - Myelocyte (Granulocyte) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Leukocyte lymphoma | Leukocyte |
0 - 1.1 |
0 - 0.6 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Leukocyte lymphoma | Leukocyte | benzo[a]pyrene (BP) (BaP) (B[a]P) |
26.7 - 66.7 |
13.3 - 33.3 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Leukocyte lymphoma | Leukocyte | Cyclosporin A |
0 - 28.6 |
0 - 30.8 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Leukocyte lymphoma | Leukocyte | diethylstilbestrol (DES) |
0 |
0 - 6.7 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Leukocyte lymphoma | Leukocyte | estradiol (E2) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Leukocyte lymphoma | Leukocyte | WY-14,643 |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Liver adenoma | Liver |
0 |
observed - 0.6 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Liver hepatocellular adenoma | Liver |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Liver hepatocellular adenoma | Liver | WY-14,643 |
0 - 26.7 |
13.3 - 40 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Liver hepatocellular carcinoma | Liver |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Liver hepatocellular carcinoma | Liver | estradiol (E2) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Liver hepatocellular carcinoma | Liver | WY-14,643 |
0 - 6.7 |
0 - 6.7 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Liver hyperplasia - oval cell | Liver |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Liver hyperplasia - oval cell | Liver | WY-14,643 |
0 - 6.7 |
13.3 - 26.7 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Liver tumor | Liver | p-cresidine |
6.7 - 20 |
0 - 53.3 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Liver tumor | Liver | 2-acetamidofluorene (2-AAF) |
46.7 |
13.3 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Lung adenoma | Lung |
0 - 0.6 |
2.2 - 6.7 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Lung adenoma | Lung | estradiol (E2) |
6.7 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Mammary gland adenocarcinoma | Mammary gland |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Mammary gland adenocarcinoma | Mammary gland | diethylstilbestrol (DES) |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Mammary gland hyperplasia - focal | Mammary gland |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||||
| Mammary gland hyperplasia - focal | Mammary gland | diethylstilbestrol (DES) |
0 - 73 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Mesodermal cell/mesoblast sarcoma | CNS - Brain |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Mesodermal cell/mesoblast sarcoma | Abdominal cavity |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Mesodermal cell/mesoblast sarcoma | Skin |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Mesodermal cell/mesoblast sarcoma | Skin | estradiol (E2) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Mesodermal cell/mesoblast sarcoma | CNS - Brain | estradiol (E2) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Mesodermal cell/mesoblast sarcoma | Abdominal cavity | estradiol (E2) |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Muscle - Smooth leiomyosarcoma | Muscle - Smooth |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Ovary - Germ cell teratoma | CNS - Brain |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||||
| Ovary - Germ cell teratoma | CNS - Brain | estradiol (E2) |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||||
| Ovary adenoma - tubulostromal | Ovary |
0.6 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||||
| Pituitary gland - Pars distalis hyperplasia | Pituitary gland - Pars distalis |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Pituitary gland - Pars distalis hyperplasia | Pituitary gland - Pars distalis | diethylstilbestrol (DES) |
0 - 87 |
0 - 60 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||
| Pituitary gland - Pars intermedia hyperplasia | Pituitary gland - Pars intermedia |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Pituitary gland - Pars intermedia hyperplasia | Pituitary gland - Pars intermedia | diethylstilbestrol (DES) |
0 - 47 |
0 - 53 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||
| Pituitary gland adenoma | Pituitary gland |
0 |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Pituitary gland adenoma | Pituitary gland | diethylstilbestrol (DES) |
0 - 13.3 |
0 - 33.3 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Placenta - Decidua deciduoma | Placenta - Decidua |
0.6 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||||
| Prostate gland - Anterior lobe metaplasia - squamous | Prostate gland - Anterior lobe |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||||
| Prostate gland - Anterior lobe metaplasia - squamous | Prostate gland - Anterior lobe | diethylstilbestrol (DES) |
0 - 60 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Testis - Germ cell teratoma | CNS - Brain |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||||
| Testis - Germ cell teratoma | CNS - Brain | estradiol (E2) |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Testis - Leydig cell (Interstitial cell) adenoma | Testis - Leydig cell (Interstitial cell) |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||||
| Testis - Leydig cell (Interstitial cell) adenoma | Testis - Leydig cell (Interstitial cell) | diethylstilbestrol (DES) |
0 - 26.7 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 ⋅ van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) |
0 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
|||||
| Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) | diethylstilbestrol (DES) |
0 - 67 |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| Thymus thymoma | Thymus |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
0 |
0 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Urinary bladder preneoplastic lesion | Urinary bladder | p-cresidine |
observed |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| Urinary bladder tumor | Urinary bladder | p-cresidine |
6.7 |
0 - 13.3 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Urinary bladder tumor | Urinary bladder | 2-acetamidofluorene (2-AAF) |
6.7 |
20 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| Uterus - Uterine gland hyperplasia | Uterus - Uterine gland | diethylstilbestrol (DES) |
observed |
References: McAnulty PA, Toxicol Pathol 2005;33(5):609-20 |
||||
| (Unspecified organ) tumor | (Unspecified organ) |
0 - 4.5 |
0 - 7.2 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
||||
| (Unspecified organ) tumor | (Unspecified organ) | benzo[a]pyrene (BP) (BaP) (B[a]P) |
66.7 - 93.3 |
26.7 - 53.3 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| (Unspecified organ) tumor | (Unspecified organ) | p-cresidine |
13.3 - 26.7 |
0 - 60 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| (Unspecified organ) tumor | (Unspecified organ) | 2-acetamidofluorene (2-AAF) |
46.7 |
26.7 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||
| (Unspecified organ) tumor | (Unspecified organ) | diethylstilbestrol (DES) |
0 - 13.3 |
0 - 53.3 |
References: van Kreijl CF, Toxicol Pathol 2001;29 Suppl():117-27 |
|||